Global Lansoprazole Market Growth 2025-2031

October 2025 | 145 pages | ID: G821ED498C3EEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Lansoprazole market size is predicted to grow from US$ 408 million in 2025 to US$ 600 million in 2031; it is expected to grow at a CAGR of 6.6% from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Lansoprazole drug in this report.

United States market for Lansoprazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Lansoprazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Lansoprazole is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Lansoprazole players cover Takeda Pharmaceutical, Teva Pharms, Sandoz, GSK, Dr. Reddy's, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LP Information, Inc. (LPI) ' newest research report, the ?Lansoprazole Industry Forecast? looks at past sales and reviews total world Lansoprazole sales in 2024, providing a comprehensive analysis by region and market sector of projected Lansoprazole sales for 2025 through 2031. With Lansoprazole sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lansoprazole industry.

This Insight Report provides a comprehensive analysis of the global Lansoprazole landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lansoprazole portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Lansoprazole market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lansoprazole and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lansoprazole.

This report presents a comprehensive overview, market shares, and growth opportunities of Lansoprazole market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Capsules
  • Tablets
  • Injection
Segmentation by Application:
  • Male
  • Female
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Takeda Pharmaceutical
  • Teva Pharms
  • Sandoz
  • GSK
  • Dr. Reddy's
  • Pfizer
  • Taj Pharma
  • Mylan
  • Cisen Pharmaceutical
  • Lepu Pharmaceuticals
  • Nang Kuang Pharmaceutical
  • Luoxin Biotechnology
  • Beijing Honglin Pharma.
  • Suzhou YUSHI Pharmaceutical Co.
  • Changzhou Siyao Pharmaceuticals
  • Youcare Pharmaceutical Group
  • HOPE PHARMA
  • Sun Pharmaceutical Industries
  • Krka
Key Questions Addressed in this Report

What is the 10-year outlook for the global Lansoprazole market?
What factors are driving Lansoprazole market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Lansoprazole market opportunities vary by end market size?
How does Lansoprazole break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Lansoprazole Annual Sales 2020-2031
  2.1.2 World Current & Future Analysis for Lansoprazole by Geographic Region, 2020, 2024 & 2031
  2.1.3 World Current & Future Analysis for Lansoprazole by Country/Region, 2020, 2024 & 2031
2.2 Lansoprazole Segment by Type
  2.2.1 Capsules
  2.2.2 Tablets
  2.2.3 Injection
2.3 Lansoprazole Sales by Type
  2.3.1 Global Lansoprazole Sales Market Share by Type (2020-2025)
  2.3.2 Global Lansoprazole Revenue and Market Share by Type (2020-2025)
  2.3.3 Global Lansoprazole Sale Price by Type (2020-2025)
2.4 Lansoprazole Segment by Application
  2.4.1 Male
  2.4.2 Female
2.5 Lansoprazole Sales by Application
  2.5.1 Global Lansoprazole Sale Market Share by Application (2020-2025)
  2.5.2 Global Lansoprazole Revenue and Market Share by Application (2020-2025)
  2.5.3 Global Lansoprazole Sale Price by Application (2020-2025)

3 GLOBAL BY COMPANY

3.1 Global Lansoprazole Breakdown Data by Company
  3.1.1 Global Lansoprazole Annual Sales by Company (2020-2025)
  3.1.2 Global Lansoprazole Sales Market Share by Company (2020-2025)
3.2 Global Lansoprazole Annual Revenue by Company (2020-2025)
  3.2.1 Global Lansoprazole Revenue by Company (2020-2025)
  3.2.2 Global Lansoprazole Revenue Market Share by Company (2020-2025)
3.3 Global Lansoprazole Sale Price by Company
3.4 Key Manufacturers Lansoprazole Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Lansoprazole Product Location Distribution
  3.4.2 Players Lansoprazole Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR LANSOPRAZOLE BY GEOGRAPHIC REGION

4.1 World Historic Lansoprazole Market Size by Geographic Region (2020-2025)
  4.1.1 Global Lansoprazole Annual Sales by Geographic Region (2020-2025)
  4.1.2 Global Lansoprazole Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Lansoprazole Market Size by Country/Region (2020-2025)
  4.2.1 Global Lansoprazole Annual Sales by Country/Region (2020-2025)
  4.2.2 Global Lansoprazole Annual Revenue by Country/Region (2020-2025)
4.3 Americas Lansoprazole Sales Growth
4.4 APAC Lansoprazole Sales Growth
4.5 Europe Lansoprazole Sales Growth
4.6 Middle East & Africa Lansoprazole Sales Growth

5 AMERICAS

5.1 Americas Lansoprazole Sales by Country
  5.1.1 Americas Lansoprazole Sales by Country (2020-2025)
  5.1.2 Americas Lansoprazole Revenue by Country (2020-2025)
5.2 Americas Lansoprazole Sales by Type (2020-2025)
5.3 Americas Lansoprazole Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Lansoprazole Sales by Region
  6.1.1 APAC Lansoprazole Sales by Region (2020-2025)
  6.1.2 APAC Lansoprazole Revenue by Region (2020-2025)
6.2 APAC Lansoprazole Sales by Type (2020-2025)
6.3 APAC Lansoprazole Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Lansoprazole by Country
  7.1.1 Europe Lansoprazole Sales by Country (2020-2025)
  7.1.2 Europe Lansoprazole Revenue by Country (2020-2025)
7.2 Europe Lansoprazole Sales by Type (2020-2025)
7.3 Europe Lansoprazole Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Lansoprazole by Country
  8.1.1 Middle East & Africa Lansoprazole Sales by Country (2020-2025)
  8.1.2 Middle East & Africa Lansoprazole Revenue by Country (2020-2025)
8.2 Middle East & Africa Lansoprazole Sales by Type (2020-2025)
8.3 Middle East & Africa Lansoprazole Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Lansoprazole
10.3 Manufacturing Process Analysis of Lansoprazole
10.4 Industry Chain Structure of Lansoprazole

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Lansoprazole Distributors
11.3 Lansoprazole Customer

12 WORLD FORECAST REVIEW FOR LANSOPRAZOLE BY GEOGRAPHIC REGION

12.1 Global Lansoprazole Market Size Forecast by Region
  12.1.1 Global Lansoprazole Forecast by Region (2026-2031)
  12.1.2 Global Lansoprazole Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Lansoprazole Forecast by Type (2026-2031)
12.7 Global Lansoprazole Forecast by Application (2026-2031)

13 KEY PLAYERS ANALYSIS

13.1 Takeda Pharmaceutical
  13.1.1 Takeda Pharmaceutical Company Information
  13.1.2 Takeda Pharmaceutical Lansoprazole Product Portfolios and Specifications
  13.1.3 Takeda Pharmaceutical Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.1.4 Takeda Pharmaceutical Main Business Overview
  13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Teva Pharms
  13.2.1 Teva Pharms Company Information
  13.2.2 Teva Pharms Lansoprazole Product Portfolios and Specifications
  13.2.3 Teva Pharms Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.2.4 Teva Pharms Main Business Overview
  13.2.5 Teva Pharms Latest Developments
13.3 Sandoz
  13.3.1 Sandoz Company Information
  13.3.2 Sandoz Lansoprazole Product Portfolios and Specifications
  13.3.3 Sandoz Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.3.4 Sandoz Main Business Overview
  13.3.5 Sandoz Latest Developments
13.4 GSK
  13.4.1 GSK Company Information
  13.4.2 GSK Lansoprazole Product Portfolios and Specifications
  13.4.3 GSK Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.4.4 GSK Main Business Overview
  13.4.5 GSK Latest Developments
13.5 Dr. Reddy's
  13.5.1 Dr. Reddy's Company Information
  13.5.2 Dr. Reddy's Lansoprazole Product Portfolios and Specifications
  13.5.3 Dr. Reddy's Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.5.4 Dr. Reddy's Main Business Overview
  13.5.5 Dr. Reddy's Latest Developments
13.6 Pfizer
  13.6.1 Pfizer Company Information
  13.6.2 Pfizer Lansoprazole Product Portfolios and Specifications
  13.6.3 Pfizer Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.6.4 Pfizer Main Business Overview
  13.6.5 Pfizer Latest Developments
13.7 Taj Pharma
  13.7.1 Taj Pharma Company Information
  13.7.2 Taj Pharma Lansoprazole Product Portfolios and Specifications
  13.7.3 Taj Pharma Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.7.4 Taj Pharma Main Business Overview
  13.7.5 Taj Pharma Latest Developments
13.8 Mylan
  13.8.1 Mylan Company Information
  13.8.2 Mylan Lansoprazole Product Portfolios and Specifications
  13.8.3 Mylan Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.8.4 Mylan Main Business Overview
  13.8.5 Mylan Latest Developments
13.9 Cisen Pharmaceutical
  13.9.1 Cisen Pharmaceutical Company Information
  13.9.2 Cisen Pharmaceutical Lansoprazole Product Portfolios and Specifications
  13.9.3 Cisen Pharmaceutical Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.9.4 Cisen Pharmaceutical Main Business Overview
  13.9.5 Cisen Pharmaceutical Latest Developments
13.10 Lepu Pharmaceuticals
  13.10.1 Lepu Pharmaceuticals Company Information
  13.10.2 Lepu Pharmaceuticals Lansoprazole Product Portfolios and Specifications
  13.10.3 Lepu Pharmaceuticals Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.10.4 Lepu Pharmaceuticals Main Business Overview
  13.10.5 Lepu Pharmaceuticals Latest Developments
13.11 Nang Kuang Pharmaceutical
  13.11.1 Nang Kuang Pharmaceutical Company Information
  13.11.2 Nang Kuang Pharmaceutical Lansoprazole Product Portfolios and Specifications
  13.11.3 Nang Kuang Pharmaceutical Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.11.4 Nang Kuang Pharmaceutical Main Business Overview
  13.11.5 Nang Kuang Pharmaceutical Latest Developments
13.12 Luoxin Biotechnology
  13.12.1 Luoxin Biotechnology Company Information
  13.12.2 Luoxin Biotechnology Lansoprazole Product Portfolios and Specifications
  13.12.3 Luoxin Biotechnology Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.12.4 Luoxin Biotechnology Main Business Overview
  13.12.5 Luoxin Biotechnology Latest Developments
13.13 Beijing Honglin Pharma.
  13.13.1 Beijing Honglin Pharma. Company Information
  13.13.2 Beijing Honglin Pharma. Lansoprazole Product Portfolios and Specifications
  13.13.3 Beijing Honglin Pharma. Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.13.4 Beijing Honglin Pharma. Main Business Overview
  13.13.5 Beijing Honglin Pharma. Latest Developments
13.14 Suzhou YUSHI Pharmaceutical Co.
  13.14.1 Suzhou YUSHI Pharmaceutical Co. Company Information
  13.14.2 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolios and Specifications
  13.14.3 Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.14.4 Suzhou YUSHI Pharmaceutical Co. Main Business Overview
  13.14.5 Suzhou YUSHI Pharmaceutical Co. Latest Developments
13.15 Changzhou Siyao Pharmaceuticals
  13.15.1 Changzhou Siyao Pharmaceuticals Company Information
  13.15.2 Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolios and Specifications
  13.15.3 Changzhou Siyao Pharmaceuticals Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.15.4 Changzhou Siyao Pharmaceuticals Main Business Overview
  13.15.5 Changzhou Siyao Pharmaceuticals Latest Developments
13.16 Youcare Pharmaceutical Group
  13.16.1 Youcare Pharmaceutical Group Company Information
  13.16.2 Youcare Pharmaceutical Group Lansoprazole Product Portfolios and Specifications
  13.16.3 Youcare Pharmaceutical Group Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.16.4 Youcare Pharmaceutical Group Main Business Overview
  13.16.5 Youcare Pharmaceutical Group Latest Developments
13.17 HOPE PHARMA
  13.17.1 HOPE PHARMA Company Information
  13.17.2 HOPE PHARMA Lansoprazole Product Portfolios and Specifications
  13.17.3 HOPE PHARMA Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.17.4 HOPE PHARMA Main Business Overview
  13.17.5 HOPE PHARMA Latest Developments
13.18 Sun Pharmaceutical Industries
  13.18.1 Sun Pharmaceutical Industries Company Information
  13.18.2 Sun Pharmaceutical Industries Lansoprazole Product Portfolios and Specifications
  13.18.3 Sun Pharmaceutical Industries Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.18.4 Sun Pharmaceutical Industries Main Business Overview
  13.18.5 Sun Pharmaceutical Industries Latest Developments
13.19 Krka
  13.19.1 Krka Company Information
  13.19.2 Krka Lansoprazole Product Portfolios and Specifications
  13.19.3 Krka Lansoprazole Sales, Revenue, Price and Gross Margin (2020-2025)
  13.19.4 Krka Main Business Overview
  13.19.5 Krka Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION



LIST OF TABLES

Table 1. Lansoprazole Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Lansoprazole Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Capsules
Table 4. Major Players ofTablets
Table 5. Major Players of Injection
Table 6. Global Lansoprazole Sales by Type (2020-2025) & (K Units)
Table 7. Global Lansoprazole Sales Market Share by Type (2020-2025)
Table 8. Global Lansoprazole Revenue by Type (2020-2025) & ($ million)
Table 9. Global Lansoprazole Revenue Market Share by Type (2020-2025)
Table 10. Global Lansoprazole Sale Price by Type (2020-2025) & (USD/Unit)
Table 11. Global Lansoprazole Sale by Application (2020-2025) & (K Units)
Table 12. Global Lansoprazole Sale Market Share by Application (2020-2025)
Table 13. Global Lansoprazole Revenue by Application (2020-2025) & ($ million)
Table 14. Global Lansoprazole Revenue Market Share by Application (2020-2025)
Table 15. Global Lansoprazole Sale Price by Application (2020-2025) & (USD/Unit)
Table 16. Global Lansoprazole Sales by Company (2020-2025) & (K Units)
Table 17. Global Lansoprazole Sales Market Share by Company (2020-2025)
Table 18. Global Lansoprazole Revenue by Company (2020-2025) & ($ millions)
Table 19. Global Lansoprazole Revenue Market Share by Company (2020-2025)
Table 20. Global Lansoprazole Sale Price by Company (2020-2025) & (USD/Unit)
Table 21. Key Manufacturers Lansoprazole Producing Area Distribution and Sales Area
Table 22. Players Lansoprazole Products Offered
Table 23. Lansoprazole Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Lansoprazole Sales by Geographic Region (2020-2025) & (K Units)
Table 27. Global Lansoprazole Sales Market Share Geographic Region (2020-2025)
Table 28. Global Lansoprazole Revenue by Geographic Region (2020-2025) & ($ millions)
Table 29. Global Lansoprazole Revenue Market Share by Geographic Region (2020-2025)
Table 30. Global Lansoprazole Sales by Country/Region (2020-2025) & (K Units)
Table 31. Global Lansoprazole Sales Market Share by Country/Region (2020-2025)
Table 32. Global Lansoprazole Revenue by Country/Region (2020-2025) & ($ millions)
Table 33. Global Lansoprazole Revenue Market Share by Country/Region (2020-2025)
Table 34. Americas Lansoprazole Sales by Country (2020-2025) & (K Units)
Table 35. Americas Lansoprazole Sales Market Share by Country (2020-2025)
Table 36. Americas Lansoprazole Revenue by Country (2020-2025) & ($ millions)
Table 37. Americas Lansoprazole Sales by Type (2020-2025) & (K Units)
Table 38. Americas Lansoprazole Sales by Application (2020-2025) & (K Units)
Table 39. APAC Lansoprazole Sales by Region (2020-2025) & (K Units)
Table 40. APAC Lansoprazole Sales Market Share by Region (2020-2025)
Table 41. APAC Lansoprazole Revenue by Region (2020-2025) & ($ millions)
Table 42. APAC Lansoprazole Sales by Type (2020-2025) & (K Units)
Table 43. APAC Lansoprazole Sales by Application (2020-2025) & (K Units)
Table 44. Europe Lansoprazole Sales by Country (2020-2025) & (K Units)
Table 45. Europe Lansoprazole Revenue by Country (2020-2025) & ($ millions)
Table 46. Europe Lansoprazole Sales by Type (2020-2025) & (K Units)
Table 47. Europe Lansoprazole Sales by Application (2020-2025) & (K Units)
Table 48. Middle East & Africa Lansoprazole Sales by Country (2020-2025) & (K Units)
Table 49. Middle East & Africa Lansoprazole Revenue Market Share by Country (2020-2025)
Table 50. Middle East & Africa Lansoprazole Sales by Type (2020-2025) & (K Units)
Table 51. Middle East & Africa Lansoprazole Sales by Application (2020-2025) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Lansoprazole
Table 53. Key Market Challenges & Risks of Lansoprazole
Table 54. Key Industry Trends of Lansoprazole
Table 55. Lansoprazole Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Lansoprazole Distributors List
Table 58. Lansoprazole Customer List
Table 59. Global Lansoprazole Sales Forecast by Region (2026-2031) & (K Units)
Table 60. Global Lansoprazole Revenue Forecast by Region (2026-2031) & ($ millions)
Table 61. Americas Lansoprazole Sales Forecast by Country (2026-2031) & (K Units)
Table 62. Americas Lansoprazole Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 63. APAC Lansoprazole Sales Forecast by Region (2026-2031) & (K Units)
Table 64. APAC Lansoprazole Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 65. Europe Lansoprazole Sales Forecast by Country (2026-2031) & (K Units)
Table 66. Europe Lansoprazole Revenue Forecast by Country (2026-2031) & ($ millions)
Table 67. Middle East & Africa Lansoprazole Sales Forecast by Country (2026-2031) & (K Units)
Table 68. Middle East & Africa Lansoprazole Revenue Forecast by Country (2026-2031) & ($ millions)
Table 69. Global Lansoprazole Sales Forecast by Type (2026-2031) & (K Units)
Table 70. Global Lansoprazole Revenue Forecast by Type (2026-2031) & ($ millions)
Table 71. Global Lansoprazole Sales Forecast by Application (2026-2031) & (K Units)
Table 72. Global Lansoprazole Revenue Forecast by Application (2026-2031) & ($ millions)
Table 73. Takeda Pharmaceutical Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceutical Lansoprazole Product Portfolios and Specifications
Table 75. Takeda Pharmaceutical Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Takeda Pharmaceutical Main Business
Table 77. Takeda Pharmaceutical Latest Developments
Table 78. Teva Pharms Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 79. Teva Pharms Lansoprazole Product Portfolios and Specifications
Table 80. Teva Pharms Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Teva Pharms Main Business
Table 82. Teva Pharms Latest Developments
Table 83. Sandoz Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 84. Sandoz Lansoprazole Product Portfolios and Specifications
Table 85. Sandoz Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Sandoz Main Business
Table 87. Sandoz Latest Developments
Table 88. GSK Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 89. GSK Lansoprazole Product Portfolios and Specifications
Table 90. GSK Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. GSK Main Business
Table 92. GSK Latest Developments
Table 93. Dr. Reddy's Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 94. Dr. Reddy's Lansoprazole Product Portfolios and Specifications
Table 95. Dr. Reddy's Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Dr. Reddy's Main Business
Table 97. Dr. Reddy's Latest Developments
Table 98. Pfizer Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 99. Pfizer Lansoprazole Product Portfolios and Specifications
Table 100. Pfizer Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Pfizer Main Business
Table 102. Pfizer Latest Developments
Table 103. Taj Pharma Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 104. Taj Pharma Lansoprazole Product Portfolios and Specifications
Table 105. Taj Pharma Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. Taj Pharma Main Business
Table 107. Taj Pharma Latest Developments
Table 108. Mylan Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 109. Mylan Lansoprazole Product Portfolios and Specifications
Table 110. Mylan Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Mylan Main Business
Table 112. Mylan Latest Developments
Table 113. Cisen Pharmaceutical Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 114. Cisen Pharmaceutical Lansoprazole Product Portfolios and Specifications
Table 115. Cisen Pharmaceutical Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Cisen Pharmaceutical Main Business
Table 117. Cisen Pharmaceutical Latest Developments
Table 118. Lepu Pharmaceuticals Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 119. Lepu Pharmaceuticals Lansoprazole Product Portfolios and Specifications
Table 120. Lepu Pharmaceuticals Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Lepu Pharmaceuticals Main Business
Table 122. Lepu Pharmaceuticals Latest Developments
Table 123. Nang Kuang Pharmaceutical Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 124. Nang Kuang Pharmaceutical Lansoprazole Product Portfolios and Specifications
Table 125. Nang Kuang Pharmaceutical Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Nang Kuang Pharmaceutical Main Business
Table 127. Nang Kuang Pharmaceutical Latest Developments
Table 128. Luoxin Biotechnology Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 129. Luoxin Biotechnology Lansoprazole Product Portfolios and Specifications
Table 130. Luoxin Biotechnology Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. Luoxin Biotechnology Main Business
Table 132. Luoxin Biotechnology Latest Developments
Table 133. Beijing Honglin Pharma. Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 134. Beijing Honglin Pharma. Lansoprazole Product Portfolios and Specifications
Table 135. Beijing Honglin Pharma. Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. Beijing Honglin Pharma. Main Business
Table 137. Beijing Honglin Pharma. Latest Developments
Table 138. Suzhou YUSHI Pharmaceutical Co. Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 139. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Product Portfolios and Specifications
Table 140. Suzhou YUSHI Pharmaceutical Co. Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Suzhou YUSHI Pharmaceutical Co. Main Business
Table 142. Suzhou YUSHI Pharmaceutical Co. Latest Developments
Table 143. Changzhou Siyao Pharmaceuticals Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 144. Changzhou Siyao Pharmaceuticals Lansoprazole Product Portfolios and Specifications
Table 145. Changzhou Siyao Pharmaceuticals Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 146. Changzhou Siyao Pharmaceuticals Main Business
Table 147. Changzhou Siyao Pharmaceuticals Latest Developments
Table 148. Youcare Pharmaceutical Group Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 149. Youcare Pharmaceutical Group Lansoprazole Product Portfolios and Specifications
Table 150. Youcare Pharmaceutical Group Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 151. Youcare Pharmaceutical Group Main Business
Table 152. Youcare Pharmaceutical Group Latest Developments
Table 153. HOPE PHARMA Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 154. HOPE PHARMA Lansoprazole Product Portfolios and Specifications
Table 155. HOPE PHARMA Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 156. HOPE PHARMA Main Business
Table 157. HOPE PHARMA Latest Developments
Table 158. Sun Pharmaceutical Industries Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 159. Sun Pharmaceutical Industries Lansoprazole Product Portfolios and Specifications
Table 160. Sun Pharmaceutical Industries Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 161. Sun Pharmaceutical Industries Main Business
Table 162. Sun Pharmaceutical Industries Latest Developments
Table 163. Krka Basic Information, Lansoprazole Manufacturing Base, Sales Area and Its Competitors
Table 164. Krka Lansoprazole Product Portfolios and Specifications
Table 165. Krka Lansoprazole Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 166. Krka Main Business
Table 167. Krka Latest Developments

LIST OF FIGURES

Figure 1. Picture of Lansoprazole
Figure 2. Lansoprazole Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Lansoprazole Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Lansoprazole Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Lansoprazole Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Lansoprazole Sales Market Share by Country/Region (2024)
Figure 10. Lansoprazole Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Capsules
Figure 12. Product Picture ofTablets
Figure 13. Product Picture of Injection
Figure 14. Global Lansoprazole Sales Market Share by Type in 2025
Figure 15. Global Lansoprazole Revenue Market Share by Type (2020-2025)
Figure 16. Lansoprazole Consumed in Male
Figure 17. Global Lansoprazole Market: Male (2020-2025) & (K Units)
Figure 18. Lansoprazole Consumed in Female
Figure 19. Global Lansoprazole Market: Female (2020-2025) & (K Units)
Figure 20. Global Lansoprazole Sale Market Share by Application (2024)
Figure 21. Global Lansoprazole Revenue Market Share by Application in 2025
Figure 22. Lansoprazole Sales by Company in 2025 (K Units)
Figure 23. Global Lansoprazole Sales Market Share by Company in 2025
Figure 24. Lansoprazole Revenue by Company in 2025 ($ millions)
Figure 25. Global Lansoprazole Revenue Market Share by Company in 2025
Figure 26. Global Lansoprazole Sales Market Share by Geographic Region (2020-2025)
Figure 27. Global Lansoprazole Revenue Market Share by Geographic Region in 2025
Figure 28. Americas Lansoprazole Sales 2020-2025 (K Units)
Figure 29. Americas Lansoprazole Revenue 2020-2025 ($ millions)
Figure 30. APAC Lansoprazole Sales 2020-2025 (K Units)
Figure 31. APAC Lansoprazole Revenue 2020-2025 ($ millions)
Figure 32. Europe Lansoprazole Sales 2020-2025 (K Units)
Figure 33. Europe Lansoprazole Revenue 2020-2025 ($ millions)
Figure 34. Middle East & Africa Lansoprazole Sales 2020-2025 (K Units)
Figure 35. Middle East & Africa Lansoprazole Revenue 2020-2025 ($ millions)
Figure 36. Americas Lansoprazole Sales Market Share by Country in 2025
Figure 37. Americas Lansoprazole Revenue Market Share by Country (2020-2025)
Figure 38. Americas Lansoprazole Sales Market Share by Type (2020-2025)
Figure 39. Americas Lansoprazole Sales Market Share by Application (2020-2025)
Figure 40. United States Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 41. Canada Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 42. Mexico Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 43. Brazil Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 44. APAC Lansoprazole Sales Market Share by Region in 2025
Figure 45. APAC Lansoprazole Revenue Market Share by Region (2020-2025)
Figure 46. APAC Lansoprazole Sales Market Share by Type (2020-2025)
Figure 47. APAC Lansoprazole Sales Market Share by Application (2020-2025)
Figure 48. China Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 49. Japan Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 50. South Korea Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 51. Southeast Asia Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 52. India Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 53. Australia Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 54. China Taiwan Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 55. Europe Lansoprazole Sales Market Share by Country in 2025
Figure 56. Europe Lansoprazole Revenue Market Share by Country (2020-2025)
Figure 57. Europe Lansoprazole Sales Market Share by Type (2020-2025)
Figure 58. Europe Lansoprazole Sales Market Share by Application (2020-2025)
Figure 59. Germany Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 60. France Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 61. UK Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 62. Italy Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 63. Russia Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 64. Middle East & Africa Lansoprazole Sales Market Share by Country (2020-2025)
Figure 65. Middle East & Africa Lansoprazole Sales Market Share by Type (2020-2025)
Figure 66. Middle East & Africa Lansoprazole Sales Market Share by Application (2020-2025)
Figure 67. Egypt Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 68. South Africa Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 69. Israel Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 70. Turkey Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 71. GCC Countries Lansoprazole Revenue Growth 2020-2025 ($ millions)
Figure 72. Manufacturing Cost Structure Analysis of Lansoprazole in 2025
Figure 73. Manufacturing Process Analysis of Lansoprazole
Figure 74. Industry Chain Structure of Lansoprazole
Figure 75. Channels of Distribution
Figure 76. Global Lansoprazole Sales Market Forecast by Region (2026-2031)
Figure 77. Global Lansoprazole Revenue Market Share Forecast by Region (2026-2031)
Figure 78. Global Lansoprazole Sales Market Share Forecast by Type (2026-2031)
Figure 79. Global Lansoprazole Revenue Market Share Forecast by Type (2026-2031)
Figure 80. Global Lansoprazole Sales Market Share Forecast by Application (2026-2031)
Figure 81. Global Lansoprazole Revenue Market Share Forecast by Application (2026-2031)